Saturday, October 31, 2026

South African Legislature Must Develop Impeachment Rules for Zuma

Matthew Clark

December 29, 2017

Jacob Zuma, Presdent of South Africa, at the World Economic Forum on Africa 2009 in Cape Town, South Africa, June 12, 2009. Photo by World Economic Forum / Eric Miller.
WASHINGTON (ViaNews) - A South African judge has ruled the country’s legislature must now set out rules of impeachment for President Jacob Zuma. The Constitutional Court judge said lawmakers “did not hold the president to account and must put in place a mechanism that could be used for the removal of the president from office,” according to the UPI. Zuma, 75, has been accused of using $15 million in state funds to upgrade his home. South Africa’s high court ordered him to pay back the money and the UPI reported he has paid back nearly $631,000. The latest ruling does not mean Zuma will be impeached, but only directs parliament to establish rules for potential impeachment proceedings. It is not the first time Zuma has faced off with the court. In October the Supreme Court reversed the decision of the National Prosecuting Authority to drop corruption charges against Zuma and ordered the president must face those charges in court. The investigation into Zuma included allegations the leader took more than $300,000 in bribes from arms dealers. The case was abandoned in 2009, before Zuma became president, according to the UPI. In August, Zuma faced his biggest test in power when he survived a vote of no-confidence by the South African parliament. 198 ministers voted for Zuma while 177 voted against and nine abstained. It was the sixth such vote to remove Zuma from office since he was elected in 2009. Earlier this month, the African National Congress – the controlling party in South Africa – elected Deputy President Cyril Ramaphosa as its leader, setting the stage for him to become the next president of the country when Zuma’s term expires in 2019. Ramaphosa was chosen over Zuma’s ex-wife Nkosazana Dlamini-Zuma by nearly 200 votes. The latest decision by the high court came with praise from South African political parties. Bantu Holomisa told SABC News his United Democratic Movement party applauded the court ruling and hopes to work with other parties in the legislature on establishing the new rules of impeachment. “We made a wise decision by calling for the National Assembly to start a process of impeaching Zuma so I think the court has given us a guideline to say go back and develop rules as soon as possible so let’s hope that the so-called new ANC will support the opposition parties and make sure that we produce these rules and regulations as soon as possible,” Holomisa said. Party leaders from the Inkatha Freedom Party and the African People’s Convention also welcomed the ruling. “We are happy that the matter has been clarified not because of president Zuma, but because the Constitution is there for everybody so anybody who will be President, whether in 10 years or 30 years, Parliament will know what to do,” said APC leader Themba Godi, to SABC. The ANC said it will “study the judgment and discuss its full implications when the National Executive Committee meets on 10th January 2018. Parliament spokesman Moloto Mothapo said the governing body “has already begun to overhaul the rules.” “We will ensure that the judgment of the court is fully implemented. Parliament had already begun a process of overhauling the rules we have recently adopted to overhaul the rules to realise [sic] Section 89,” Mothapo told SABC News.
What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Catalyst Cluster: Ivonescimab's PDUFA Date and Small-Cap Biotech Delistings
ESMO 2026 (Oct 22-24) concentrates a wave of oncology readouts. Summit's ivonescimab (10 presentations, positive HARMONi-GI1 OS, new EA2251 Phase II/III with ECOG-ACRIN) leads, ahead of its FDA PDUFA date of 2026-11-14, and Daiichi Sankyo's DXd ADC platform (REJOICE-Ovarian, DESTINY-Lung04, TUXEDO-3) follows. At the other end of the capital-markets spectrum, micro-cap Spago Nanomedical is moving to delist from Nasdaq First North (board resolution Oct 22, EGM Nov 19, application Jan 2027). Pivotal data and regulatory milestones are rewarding well-funded late-stage players, while cash-constrained early-stage developers are exiting public markets.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,995
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,995 facts checked against source5,525 source documents archived
Query this data → isubstrate.com